These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32070865)

  • 1. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
    Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X
    Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
    Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
    Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy.
    Zhang Q; Neoh KG; Xu L; Lu S; Kang ET; Mahendran R; Chiong E
    Langmuir; 2014 Jun; 30(21):6151-61. PubMed ID: 24824061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
    Yuan X; Peng S; Lin W; Wang J; Zhang L
    J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
    Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulation of gadolinium ferrite nanoparticle in generation 4.5 poly(amidoamine) dendrimer for cancer theranostics applications using low frequency alternating magnetic field.
    Mekonnen TW; Birhan YS; Andrgie AT; Hanurry EY; Darge HF; Chou HY; Lai JY; Tsai HC; Yang JM; Chang YH
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110531. PubMed ID: 31590053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
    Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
    Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy.
    Amin MU; Ali S; Ali MY; Tariq I; Nasrullah U; Pinnapreddy SR; Wölk C; Bakowsky U; Brüßler J
    Eur J Pharm Biopharm; 2021 Aug; 165():31-40. PubMed ID: 33962002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.
    Shahabi S; Döscher S; Bollhorst T; Treccani L; Maas M; Dringen R; Rezwan K
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26880-91. PubMed ID: 26562468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles.
    Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM
    J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
    Tambe P; Kumar P; Paknikar KM; Gajbhiye V
    Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulus-responsive nanomotors based on gated enzyme-powered Janus Au-mesoporous silica nanoparticles for enhanced cargo delivery.
    Llopis-Lorente A; García-Fernández A; Lucena-Sánchez E; Díez P; Sancenón F; Villalonga R; Wilson DA; Martínez-Máñez R
    Chem Commun (Camb); 2019 Oct; 55(87):13164-13167. PubMed ID: 31620732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica templated-albumin nanoparticles with high doxorubicin payload for drug delivery assessed with a 3-D tumor cell model.
    Ménard M; Meyer F; Parkhomenko K; Leuvrey C; Francius G; Bégin-Colin S; Mertz D
    Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):332-341. PubMed ID: 30391506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
    Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
    Zhang K; Zhou D; Wang Z; Zhang Y; He P
    Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.